BD's Medical Segment Divests Ophthalmic Biz To Refocus On Drug Delivery
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson's Medical division will refocus on drug delivery products after divesting its Ophthalmic Systems unit and certain other businesses under a June 8 agreement